Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

• Conditions: Sepsis Septic Shock

• Registration Number: NCT03000049
• Lead Sponsor: University Medicine Greifswald

Brief Summary

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobial therapy in patients with sepsis and septic shock.

Prospective observational, open-label mono-center study to compare a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System and Curetis Univero System) with standard blood culture diagnostics in patients with sepsis or septic shock.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-11
• Status Verified: 2016-12
• Study First Submitted: 2016-12-15
• Study First Submitted QC: 2016-12-18
• Study First Posted: 2016-12-21
• Last Update Submitted: 2016-12-21
• Last Update Posted: 2016-12-22
• Primary Completion: 2017-07
• Study Completion: 2017-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Patients with a new diagnosed sepsis or septic shock: emergency department, operating theatre, intensive care unit and planed blood culture diagnostics.
• informed written consent

Exclusion Criteria

• Pediatric patients (< 18 Years)
• DNR-order

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time to a significant change of antimicrobial therapy from the time of the diagnosis of sepsis or septic shock	Nov. 2016 - Nov. 2017

Trial Locations

Locations (1)

Anesthesiology and Intensive Care Medicine Department, University of Greifswald, Germany; 🇩🇪 Greifswald, Germany